Skip to content
Announcement:

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

Lung Platform Capabilities

Find out more about our lung airway models here

Read about our case study on Quantitative Fibroblast-to- Myofibroblast Transition (FMT) studies here 

Discover our blog on Overcoming optimisation hurdles of high-throughput FMT assay

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

Get our latest updates straight to your inbox